Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADIANT Study
NCT06393868Phase 3Recruiting
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Nov 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omeprazole in gastrointestinal bleeding, sponsored by Ottawa Hospital Research Institute. Started Nov 2024; status: recruiting.
02
Drugs
omeprazole
03
Conditions
gastrointestinal bleeding
Beyond the preview
Go deeper on NCT06393868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06393868.